Skin permeation of buflomedil form adhesive matrix patches
Source abstract
Abstract
The main objective of this research work was to fabricate and evaluate adhesive matrix-type transdermal patches of buflomedil hydrochloride, employing different ratios of pressure sensitive adhesives (PSAs) by solvent casting technique. The adhesive matrix-type transdermal patches were evaluated by their in vitro physicochemical properties such as thickness, moisture content, weight variation, drug content uniformity, etc. The effects of PSAs ratio, drug loading, and concentration of permeation enhancer were evaluated thoroughly. Ex vivo skin permeation studies with kinetic modeling of adhesive matrix patches were systematically evaluated. Based on the above observations, the best optimized buflomedil hydrochloride-loaded adhesive matrix-type transdermal patch was further characterized by scanning electron microscopy, Fourier transform infrared spectroscopy, X-ray diffraction study, and differential scanning calorimetry analyses. Drug containing adhesive matrix patches showed sustained release property without showing any incompatibility in adhesive matrix system. Hence, adhesive matrix-type transdermal patches of buflomedil hydrochloride can be used as a potential carrier for sustained transdermal delivery of hydrophilic drugs like buflomedil hydrochloride.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Advanced Drug Delivery Systems · Drug Solubulity and Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (16)
Show source-provided references
1. 10.1002/j.1552-4604.1991.tb01895.x10.1002/j.1552-4604.1991.tb01895.x ↗
2. 10.1016/S0378-5173(99)00380-410.1016/S0378-5173(99)00380-4 ↗
3. 10.1248/bpb.28.30510.1248/bpb.28.305 ↗
4. 10.1001/jama.285.18.234710.1001/jama.285.18.2347 ↗
5. 10.1177/00033197810320100110.1177/000331978103201001 ↗
6. 10.1016/j.ijadhadh.2014.01.00110.1016/j.ijadhadh.2014.01.001 ↗
7. Madishetti SK · DARU · 2010 · 18 · 221
8. Damodharan N · Pharm. Technol · 2010 · 34 · 56
9. Mukherjee B · Pharm. Technol · 2006 · 30 · 146
10. 10.1016/j.ejpb.2004.09.00910.1016/j.ejpb.2004.09.009 ↗
11. 10.1016/j.carbpol.2013.01.07010.1016/j.carbpol.2013.01.070 ↗
12. 10.1016/j.jfda.2014.01.02210.1016/j.jfda.2014.01.022 ↗
13. Wyatt DA · 1999 · 92 · 31
14. 10.1002/(ISSN)1520-601710.1002/(ISSN)1520-6017 ↗
15. 10.1016/0378-5173(83)90064-910.1016/0378-5173(83)90064-9 ↗
16. 10.1081/DDC-12002871610.1081/DDC-120028716 ↗